Amedisys (AMED) Talked Up On CNBC

Amedisys (Nasdaq: AMED) was just spoken about on CNBC with Erin Burnett by Meditron Asset Management founder and chief investment strategist Walter Gerasimowicz. He spent a few minutes talking about Amedisys, telling viewers that AMED is a great a health care company that brings down costs and it is perfectly positioned for a lower cost environment when serving a client in home.

He told CNBC, "This (Amedisys) is one of the largest health-care providers in the country.".� "This is one of those non-cyclical, almost recession-proof
growth stocks, which will be with us for many years to come."

Additionally, he said Amedisys is growing through accretive acquisitions and earnings are growing at 30% plus per annum. Well, who's right, Citron or investment strategist Walter Gerasimowicz.

Amedisys, Inc. (Amedisys) is a provider of home health services to the chronic, co-morbid, aging American population.
Sign up at EasyStockAlerts.com To Be Alerted To Your Stock News Today!

You May Also Be Interested In

• Trump says to rename Lake Ontario to Lake America
• FDA: issues early alert on Abiomed heart pump controller purge cassette issue
• Okta, Inc. (OKTA) Spike Tied to Chatter of Earnings Leak, Beat